Canagliflozin: Effects in overweight and obese subjects without diabetes mellitus

OBJECTIVE: To evaluate the effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on body weight in overweight and obese subjects (body mass index [BMI] ≥27 and <50 kg/m(2)). METHODS: This 12-week, Phase 2b, randomized, double-blind study enrolled 376 subjects without diabetes mel...

Descripción completa

Detalles Bibliográficos
Autores principales: Bays, Harold E, Weinstein, Richard, Law, Gordon, Canovatchel, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285787/
https://www.ncbi.nlm.nih.gov/pubmed/24227660
http://dx.doi.org/10.1002/oby.20663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285787/
https://www.ncbi.nlm.nih.gov/pubmed/24227660
http://dx.doi.org/10.1002/oby.20663

Ejemplares similares